ASO Author Reflections: Is ctDNA Detection an Accurate Measure of the Risk of Recurrence in Patients Undergoing Neoadjuvant Treatment?

Saved in:
Bibliographic Details
Title: ASO Author Reflections: Is ctDNA Detection an Accurate Measure of the Risk of Recurrence in Patients Undergoing Neoadjuvant Treatment?
Authors: Gögenur M; Center for Surgical Science, Zealand University Hospital Køge, Lykkebækvej 1, 4600, Køge, Denmark. mgog@regsj.dk., Lindbjerg Andersen C; Danish Colorectal Cancer Group, Copenhagen, Denmark.; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Gögenur I; Center for Surgical Science, Zealand University Hospital Køge, Lykkebækvej 1, 4600, Køge, Denmark.; Danish Colorectal Cancer Group, Copenhagen, Denmark.
Source: Annals of surgical oncology [Ann Surg Oncol] 2022 Dec; Vol. 29 (13), pp. 8675. Date of Electronic Publication: 2022 Aug 05.
Publication Type: Journal Article; Comment
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1534-4681
DOI:10.1245/s10434-022-12378-3